# Sildenafil

## VIAGRA 100mg (4 tablets/box)

| 藥物代碼           | OVGR1                                                                                                                                                                                                                                                                                                                                                                                                                                         |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of erectile dysfunction.                                                                                                                                                                                                                                                                                                                                                                                                            |
| 副作用             | Headache, flushing, dizziness, dyspepsia, nasal congestion, altered vision.Dermatologic: Erythema (6% ), Flushing (10% )Gastrointestinal: Indigestion (4% to 17% )Neurologic: Headache (16% to 46% ), Insomnia (up to 7% )Ophthalmic: Visual disturbance (3% to 11% )Respiratory: Epistaxis (3% to 9% ), Nasal congestion (4% ), Rhinitis (4% )                                                                                               |
| 禁忌               | Patients who use nitric oxide donors or nitrates. Viagra should not be used in men for whom sexual activity is inadvisable (patients with severe CV disorders eg unstable angina or severe cardiac failure). Severe hepatic impairment, hypotension (< 90/50 mm Hg) or hypertension (> 170/100 mm Hg), recent history of stroke or MI, known hereditary degenerative retinal disorders such as retinitis pigmentosa. Not indicated for women. |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Adult 50-100 mg once daily, taken approximately 25-60 min before sexual activity. Max: 100 mg once daily. Hepatic impairment (eg. cirrhosis, 80%), severe renal impairment (creatinine clearance < 30 mL/min, 100%), and concomitant of potent cytochrome P450 3A4 inhibitors; Starting dose of 25 mg should be considered, may increase to 50-100 mg based on efficacy & toleration. Max dosing frequency is once per day.                   |
| 肝功能異常         | 需 調 整 劑 量  肝功能受損之患者(如肝硬化)患者的清除率會下降，因此應考慮使用25 mg的起始劑量。基於藥效及耐受的考量，劑量可提高至50 mg或100 mg                                                                                                                                                                                                                                                                                                  |
| 腎功能異常         | 需 調 整 劑 量                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                        |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                           |

## Viagra ODT 50mg (4 tablets/box)

| 藥物代碼           | OVGRO                                                                                                                                        |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | NA                                                                                                                                           |
| 副作用             | NA                                                                                                                                           |
| 禁忌               | NA                                                                                                                                           |
| 藥物保存方式       | N/A                                                                                                                                          |
| 用法用量           | N/A                                                                                                                                          |
| 肝功能異常         | 需 調 整 劑 量  肝功能受損之患者(如肝硬化)患者的清除率會下降，因此應考慮使用25 mg的起始劑量。基於藥效及耐受的考量，劑量可提高至50 mg或100 mg |
| 腎功能異常         | 需 調 整 劑 量                                                                                                                               |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                     |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest low risk                                                                                       |
| 附帶說明           | N/A                                                                                                                                          |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity(Mother) 無(很少)資料 - 避免使用(母體)                                                           |
| 附帶說明           | N/A                                                                                                                                          |
| 注射劑給藥建議途徑 | N/A                                                                                                                                          |
| 乾粉稀釋液         | N/A                                                                                                                                          |
| 輸注點滴液         | N/A                                                                                                                                          |
| IVP 用法建議       | N/A                                                                                                                                          |
| IVD 用法建議       | N/A                                                                                                                                          |
| 注意事項           | N/A                                                                                                                                          |

